TITLE

The impact of acute reduction of continuous-flow left ventricular assist device support on cardiac and exercise performance

AUTHOR(S)
Jakovljevic, Djordje G.; George, Robert S.; Nunan, David; Donovan, Gay; Bougard, Robert S.; Yacoub, Magdi H.; Birks, Emma J.; Brodie, David A.
PUB. DATE
September 2010
SOURCE
Heart;Sep2010, Vol. 96 Issue 17, p1390
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background The use of the HeartMate II continuous-flow left ventricular assist device (LVAD) improves survival, quality of life and functional capacity of patients with advanced heart failure. However, no study so far has shown the benefits of these devices for cardiac function during peak exercise. Objective To assess cardiac and exercise performance in patients implanted with the HeartMate II LVAD under two settings: (i) optimal device support and (ii) reduced device support. Methods Twelve patients implanted with a HeartMate II LVAD performed a graded cardiopulmonary exercise test with respiratory gas exchange and non-invasive (rebreathing) haemodynamic measurements. After a 4 h resting period, patients performed an additional cardiopulmonary exercise test with reduced LVAD support (pump speed was reduced from optimal 9000-9600 to 6000 revs/min). Results In response to reduced HeartMate II LVAD support, resting cardiac power output and cardiac output decreased by 21% and 13%, respectively. Also at reduced device support, peak exercise cardiac power output was 39% lower (1.40±0.50 vs 2.31±0.58 W; p<0.05), peak cardiac output 30% lower (8.6±2.5 vs 12.2±2.1 l/min; p<0.05) and mean blood pressure 13% lower (74.3±14.9 vs 85.4±15.4 vs mm Hg; p<0.05). Exercise capacity was also diminished with 23% lower peak oxygen consumption (14.1±5.3 vs 18.2±4.5 ml/kg/min; p<0.05) and an 18% shorter exercise duration (516±119 vs 628±192 s; p<0.05). Conclusion It has been shown for the first time that the HeartMate II LVAD can confer both resting and peak cardiac functional benefits to patients with end-stage heart failure, thus improving exercise capacity.
ACCESSION #
55416196

 

Related Articles

  • INTRAOPERATIVE TRANSESOPHAGEAL ECHOCARDIOGRAPHY AND ANESTHETIC CONSIDERATIONS IN PATIENTS WITH VENTRICULAR ASSIST DEVICES. Kristović, Darko // Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanost;Jan2011, Vol. 509 Issue 36, p67 

    A ventricular assist device (VAD) is inserted to provide mechanical circulatory support. A VAD can rest the myocardium and allow it to recover from stunning or hibernation, while maintaining vital organ perfusion (bridge-to-recovery). If myocardial recovery cannot occur, the goal is to support...

  • THE FIRST CLINICAL USE OF HEART MATE II LEFT VENTRICULAR ASSIST SYSTEM IN CROATIA AS A BRIDGE-TO-TRANSPLANT: A CASE REPORT. Planinc, Mislav; Sutlić, Željko; Barić, Davor; Šikić, Jozica; Bradić, Nikola; Rudež, Igor; Unić, Daniel; Legac, Ante; Jonjić, Dubravka; Mrkonjić, Ruža; Čekol, Zorana // Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanost;Jan2011, Vol. 509 Issue 36, p93 

    Left ventricular assist systems (LVAS) are widely accepted nowadays as a successful tool for bridging the patients with end-stage heart failure to heart transplantation (BTT). The second generations of axial-low devices, such as the HeartMate II, provide a safe and reliable, as well as an...

  • A modified Park's stitch to correct aortic insufficiency for bioprosthetic valve at time of left ventricular assist device implant: a case report. Toshinobu Kazui; Sydow, Nicole; Friedman, Mark; Kim, Samuel; Lick, Scott; Khalpey, Zain // Journal of Cardiothoracic Surgery;11/30/2016, Vol. 11, p1 

    Background: Aortic valve insufficiency (AI) at the time of left ventricular assist device (LVAD) insertion needs to be corrected, however there is little known about how to manage bioprosthetic valvular AI. Case presentation: A 55-year-old female with dilated cardiomyopathy who previously had a...

  • POSTOPERATIVE MANAGEMENT OF PATIENTS AFTER VAD IMPLEMENTATION. Bradić, Nikola; Planinc, Mislav; Barišin, stjepan // Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanost;Jan2011, Vol. 509 Issue 36, p41 

    After the implantation of the left ventricular assisted device (LVAD), patients are admitted in intensive care unit (ICU). During the period of first several days, the goal of the postoperative care is to stabilize the patients' hemodynamics. Monitoring the continuous cardiac output, filling...

  • Left ventricular support adjustment to aortic valve opening with analysis of exercise capacity. Camboni, Daniele; Lange, Tobias J.; Ganslmeier, Patrycja; Hirt, Stephan; Flörchinger, Bernhard; Zausig, York; Rupprecht, Leopold; Hilker, Michael; Schmid, Christof // Journal of Cardiothoracic Surgery;2014, Vol. 9 Issue 1, p1 

    Background LVAD speed adjustment according to a functioning aortic valve has hypothetic advantages but could lead to submaximal support. The consequences of an open aortic valve policy on exercise capacity and hemodynamics have not yet been investigated systematically. Methods Ambulatory...

  • Circulatory support exceeding five years with a continuous-flow left ventricular assist device for advanced heart failure patients. Schmitto, Jan D.; Hanke, Jasmin S.; Rojas, Sebastian; Avsar, Murat; Malehsa, Doris; Bara, Christoph; Strueber, Martin; Haverich, Axel // Journal of Cardiothoracic Surgery;Aug2015, Vol. 10 Issue 1, p1 

    Continuous-flow left ventricular assist devices (CF-LVAD) are now providing years of safe circulatory support with enhanced quality of life. We present four cases of patients with advanced heart failure who received support for greater than 5-years with the HeartMate II CF-LVAD. One patient...

  • The Comparative Use of Ventricular Assist Devices. Birks, Emma J. // Texas Heart Institute Journal;2010, Vol. 37 Issue 5, p565 

    The article reports on the comparative use of ventricular assist devices (VAD) in European countries and the U.S. It says that the estimated number of long-term VADs implanted in the U.S. per year is much more than that in Europe, especially because European countries only fund them as a bridge...

  • Circulite gives update on Synsery clinical data.  // Medical Device Daily;4/23/2012, Vol. 16 Issue 78, p6 

    The article focuses on an update reported by Circulite related to its Synergy miniature ventricular support system. The firm said that an updated Synergy clinical data was presented in two oral presentations and one poster session at the International Society for Heart and Lung Transplantation's...

  • OVERVIEW OF THE CURRENT BENEFITS AND RISKS OF CONTINUOUS-FLOW LEFT VENTRICULAR ASSIST DEVICES. Estep, Jerry D.; Loebe, Matthias // Methodist DeBakey Cardiovascular Journal;Jan2015, Vol. 11 Issue 1, p2 

    An introduction is presented in which the authors discuss various reports within the issue on topics including the clinical importance of pre- and post-left ventricular assist device (LVAD), the challenges faced by heart failure specialists for caring for patients on continuous-flow LVADs, and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics